2017 APSR Congress
Scientific Programme
Friday 24 November 2017
- 07:00–08:15
Sponsored Breakfast Session 1: Optimising patient outcomes in COPD - management in 2017 and beyond
Sponsored by Boehringer Ingelheim- 07:00–07:05
Welcome and introduction
Speaker: Christine Jenkins, AU - 07:05–07:30
Foundation therapy in COPD: Optimising patient outcomes with the emphasis on reducing future risk
Speaker: David MG Halpin, UK - 07:30–07:50
Add-on therapy in COPD: Defining the role for ICS using an individualised approach
Speaker: Christine Jenkins, AU - 07:50–08:00
Q and A
- 07:00–07:05
Sponsored Breakfast Session 2: Exploring the bronchial tree in asthma management - large airways, small airways and clinical outcomes
Sponsored by Mundipharma Pte Ltd
Room: Theatrette 2, Exhibition Hall- 07:00–07:15
Asthma control in Australia - doing better, going forward?
Speaker: Greg King, AU - 07:15–07:35
Does size matter? The importance of small airway disease in treatment of asthma with ICS/LABAs
Speaker: Omar S Usmani, UK - 07:35–07:55
Asthma exacerbation with ICS/LABA - evidence from RCTs and the real world
Speaker: Alberto Papi, Italy - 07:55–08:10
Q&Amp;A
- 07:00–07:15
- 08:30–10:00
Critical Care 1: A safer place for patients and clinicians
Room: C3.4 & C3.5- 08:30–09:00
Identification and management of burnout in critical care physicians
Speaker: Marc Moss, US - 09:00–09:30
Clinical trial in critical care: A means to improve outcomes
Speaker: Polly Parsons, US - 009:30–10:00
Using high fidelity simulation to teach crisis resource management in critical care
Speaker: Gerald Chua, Singapore
- 08:30–09:00
Lung Cancer 1: Lung cancer diagnosis and treatment
Room: Darling Harbour Theatre- 08:30–09:00
Heterogeneity in lung cancer and lung cancer practice in Asia-Pacific region
Speaker: Yoichi Nakanishi, Japan - 09:00–09:30
Diagnosis and management of resistance and persistence in molecularly defined NSCLC
Speaker: Chong-Kin Liam, Malaysia - 09:30–10:00
Pulmonary toxicity with PD-1 inhibitors and other novel cancer treatments
Speaker: Mina Gaga, Greece
- 08:30–09:00
Respiratory Structure and Function: What have we learned about the small airways?
Room: C3.3- 08:30–08:50
Studying small airways in health and disease
Speaker: Jane Bourke, AU - 08:50–09:10
Lessons from ex-vivo studies on small airways: Role of intrinsic smooth muscle tone in airway disease
Speaker: Peter Noble, AU - 09:10–09:30
In vivo/clinical mechanics of small airway narrowing
Speaker: Cindy Thamrin, AU - 09:30–10:00
Functional imaging of the small airways
Speaker: Kim Prisk, US
- 08:30–08:50
-
Oral Presentations: Asthma 1
Room: E3.4- 08:30–08:40
Clinical Utility of Feno Analysis in the Diagnosis of Cough-Variant Asthma
Speaker: Binu Krishnan, India - 08:40–08:50
Comparison of Fractional Exhaled Nitric Oxide Values Measured Using NOA208i and NIOX VERO
Speaker: Yoshinari Endo, Japan - 08:50–09:00
Comparative Responses in Lung Function Measurements in Adolescents and Adults With Moderate Symptomatic Asthma
Speaker: David Halpin, UK - 09:00–09:10
Patient-Reported Activity Impairment, Stress, and Tiredness Improvement in Patients with Severe, Uncontrolled Asthma with Eosinophilic Inflammation: Pooled Results from Two Phase III Trials of Benralizumab
Speaker: Xiao Xu, US - 09:10–09:20
Diurnal Variability in Peak Expiratory Flow with Tiotropium Respimat in Adults with Severe, Moderate and Mild Symptomatic Asthma
Speaker: Huw Davies, AU - 09:20–09:30
Forced Vital Capacity Response to Tiotropium Respimat in Adult Patients with Severe, Moderate and Mild Symptomatic Asthma
Speaker: Peter Frith, AU - 09:30–09:40
Fevipiprant Reduces Airway Smooth Muscle Mass in Asthmatics via PGD2 Receptor Antagonism
Speaker: Marcela Gavornikova, Switzerland
- 08:30–08:40
Oral Presentations: COPD 1
Room: E3.10- 08:30–08:40
Comparison of World Health Organization and Asia-Pacific Body Mass Index Classifications in COPD Patient
Speaker: Chin Kook Rhee, Republic of Korea - 08:40–08:50
Peripheral Atherosclerosis in Non-Smokers with Airflow Limitation
Speaker: Joo Hun Park, Republic of Korea - 08:50–09:00
Dietary Fibre and Microbial Metabolites Protect Against Cigarette Smoke-Induced Lung Pathology in Mice
Speaker: Kurtis Budden, AU - 09:00–09:10
Vitamin E Isoform Gamma-Tocotrienol Protects Against Emphysema Development in Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
Speaker: Wai Shiu Fred Wong, Singapore - 09:10–09:20
Investigation on the Individual Characteristics of Inflammatory Cytokines on COPD Patients
Speaker: In Ae Kim, Republic of Korea - 09:20–09:30
Eosinophilia is Less Likely to Occur in COPD Smokers with Emphysema Phenotype
Speaker: Nguyen Van Tho, Vietnam - 09:30–09:40
Sputum 6 Gene Expression Signature Predicts Inflammatory Phenotype of Chronic Obstructive Pulmonary Disease
Speaker: Katie Baines, AU - 09:40–09:50
Restoration of Corticosteroid Sensitivity in Cigarette Smoke-Induced Lung Injury Model by Andrographolide
Speaker: Wupeng Liao, Singapore
- 08:30–08:40
Oral Presentations: Tuberculosis 1
Room: E3.9- 08:30–08:40
Risk Factors for Delayed Diagnosis of Pulmonary Tuberculosis in Intermediate TB Burden Country
Speaker: Gyung Eui Lee, Republic of Korea - 08:40–08:50
Prevalence and Risk Factors of Drug Resistant Extrapulmonary Tuberculosis
Speaker: Viboon Boonsarngsuk, Thailand - 08:50–09:00
The Nutritional Status Assessed by Malnutrition Screening Tools in Pulmonary Tuberculosis and its Relation to Bacterial Load
Speaker: Anggar Jito, Indonesia - 09:00–09:10
To Assess Risk Factors for "Lost to Follow-up" in the Treatment for Tuberculosis - Analysis of Japan TB Surveillance Data
Speaker: Lisa Kawatsu, Japan - 09:10–09:25
Recurrent Pyopneumothorax in Multi Drug Resistant Tuberculosis Patient: A Case Report
Speaker: Dian Prastiti Utami, Indonesia - 09:25–09:35
Latent Tuberculosis Infection Increases in Patients Receiving Kidney Transplantation
Speaker: Chin-Chung Shu, Taiwan - 09:35–09:45
Pulmonary Tuberculosis Associated with Interstitial Lung Disease
Speaker: Atsushi Nakagawa, Japan
- 08:30–08:40
- 10:00–10:30
Morning Tea & Exhibition Viewing
Room: Exhibition Hall - 10:30–11:30
Plenary: Memorial Lecture: Ann Janet Woolcock Research Award
Room: Darling Harbour Theatre- 10:30–10:35
Introduction
- 10:35–11:20
Airway hyperresponsiveness - does it take two to tango?
Speaker: Alan James, AU - 11:20–11:30
Award presentation
- 10:30–10:35
- 11:30–13:00
Asthma 1: Post Lancet Commission - Asthma is an outdated concept - a pro/con debate
Room: Darling Harbour Theatre- 11:30–11:35
Introduction
Speaker: Alan James and Kang Yun Lee - 11:35–11:50
Pro
Speaker: Andrew Bush, UK - 11:50–12:05
Con
Speaker: Fan Chung, UK - 12:05–12:20
Pro
Speaker: Peter Gibson, AU - 12:20–12:35
Con
Speaker: Gary Anderson, AU - 12:35–12:40
Pro rebuttal
Speaker: Andrew Bush, UK - 12:40–12:45
Con rebuttal
Speaker: Fan Chung, UK - 12:45–13:00
Questions and voting
- 11:30–11:35
Interstitial Lung Disease 1: Exacerbations and potential therapies of IPF
Room: C3.4 & C3.5- 11:30–12:00
Novel antifibrotic therapies in IPF and CLAD
Speaker: Simon Royce, VIC - 12:00–12:30
Basic mechanisms of exacerbations in association with AIP
Speaker: Masahito Ebina, Japan - 12:30–13:00
Novel therapies for IPF exacerbations
Speaker: Shinji Abe, Japan
- 11:30–12:00
Respiratory Neurobiology and Sleep: Hypoxia
Room: C3.3- 11:30–12:00
Effects of hypoxia on the sensorimotor control of upper airway
Speaker: Peter Burke, Australia - 12:00–12:30
Effects of hypoxia on the brainstem neural network function
Speaker: Yoshitaka Oku, Japan - 12:30–13:00
Effects of hypoxia on metabolism and cardiovascular function
Speaker: Chris O'Donnell, US
- 11:30–12:00
Oral Presentations: Cellular and Molecular Biology
Room: E3.4- 11:30–11:40
Mesenchymal Stem Cell-Conditioned Medium Induces Neutrophils Apoptosis via Inhibition of NF-KB Pathway in Endotoxin-Induced Acute Lung Injury
Speaker: Chi-Shiuan Lin, Taiwan - 11:40–11:50
Bronchiolitis Obliterans Syndrome is Associated with Increased P-Glycoprotein Expression and Loss of Glucocorticoid Receptor from Steroid Resistant Pro-Inflammatory CD8+T Cells
Speaker: Greg Hodge, AU - 11:50–12:00
Enhanced CD147 Expression after H1N1 Infection; a Potential Mechanism for Airway Epithelium Impairment in Asthma
Speaker: Fatemeh Moheimani, AU - 12:00–12:10
Dietary Omega-6, but not Omega-3 Polyunsaturated or Saturated Fatty Acids Increase Inflammation in Human Pulmonary Fibroblasts
Speaker: Sandra Rutting, AU - 12:10–12:20
The Role of PM2.5 played in Cigarette Smoke-Inflamed Pulmonary Epithelium
Speaker: Tianyu Zhou, China - 12:20–12:30
Investigation of the CD1B Lipid Antigen Presentation Pathway in COPD
Speaker: Miranda Ween, AU - 12:30–12:40
Rage-Specific Antagonist Alleviates Elastase-Induced Emphysema Development by Preventing Rage-Damp Signaling
Speaker: Hanbyeol Lee, Republic of Korea - 12:40–12:55
Role of Quiescence Cancer Stem Cells in rhe Gefitinib Resistance in EGFR Mutation-Positive Non-Small Cell Lung Cancer
Speaker: Moulid Hidayat, Japan
- 11:30–11:40
Oral Presentations: Clinical Respiratory Medicine 1
Room: E3.9- 11:30–11:50
Illicit tobacco in Sydney has declined not increased after introduction of mandatory plain tobacco packaging – results from a four year study
Speaker: Matthew Peters, AU - 11:50–12:00
Health Impact of E-Cigarettes: A Prospective 3.5-year Study of Regular Users Who Have Never Smoked
Speaker: Riccardo Polosa, Italy - 12:00–12:10
The Stages of Change (SOC) and the Long-Term Outcome of an Outpatient Smoking-Cessation Programme with Medically Ill Smokers
Speaker: Michelle Shi, Singapore - 12:10–12:20
A Retrospective Study on Amiodarone Pulmonary Toxicity in Chinese Patients in Hong Kong
Speaker: Wang Chun Kwok, Hong Kong - 12:20–12:30
A Case Series of Hereditary Cystic Lung Disease in a Chinese Family
Speaker: Cheung Wai Eric Sze, Hong Kong - 12:30–12:40
A Familial Case of Birt-Hogg-Dube Syndrome (BHDS) Complicated with Bladder Cancer and Lung Cancera Case Report and Literature Review
Speaker: Yuki Goto, Japan - 12:40–12:50
A Rare Presentation of Bronchogenic Cyst with Atrial Fibrilation
Speaker: Chakrahari Ugandhar Bhattu, India
- 11:30–11:50
Oral Presentations: Lung Cancer 1
Room: E3.10- 11:30–12:00
Mechanism of acquired resistance to anti-angiogenic therapy mediated by fibrocytes
Speaker: Hisatsugu Goto, Japan - 12:00–12:10
GSK-3 Inhibition Suppresses Lung Cancer Cell Survival, Metastasis and Proliferation Through Down-Regulation the Phosphorylation Sites of CAP1
Speaker: Changhui Wang, China - 12:10–12:20
The Role of Zinc Finger E-Box Binding Homeobox 1 in the Hypoxia-Induced CD133 Upregulation and Self-Renewal Capacity in Non-Small Cell Lung Cancer
Speaker: Fariz Nurwidya, Indonesia - 12:20–12:30
The effect of miR-21 on the proliferation, migration and apoptosis of lung A549 cells
Speaker: Yonghua Zheng,China - 12:30–12:40
The Expression and Significance of MIR-21A-5P And MIR-21A-3P in BALB/C Mice Pulmonary Precancerous Lesions Induced by Fine Particulate Matter
Speaker: Tian-Fang Hou, China - 12:40–12:50
Glutathione S-Transferase M1 And T1 Polymorphisms Prevalence in Lung Cancer Patients in Malang, Indonesia
Speaker: Rezki Tantular, Indonesia
- 11:30–12:00
Oral Presentations: Respiratory Infections (Non-TB) 1
Room: E3.8- 11:30–11:40
Aetiology of Community Acquired Pneumonia with Fever and the Presentation and Prognosis of Viral Infection: A Prospective Observational Study
Speaker: Jin-Fu Xu, China - 11:50–12:00
Risk Stratification for the Development of Chronic Pulmonary Aspergillosis in Patients with Mycobacterium Avium Complex Lung Disease
Speaker: Koji Furuuchi, Japan - 12:00–12:10
Association between implementation of "bundles of care" and possible ventilator associated pneumonia (PVAP) among mechanically ventilated patients in the intensive care unit: A quasi-experimental study
Speaker: Patricia Ann Estrella, Philippines - 12:10–12:20
Modification of Curb-65 Score as Mortality Predictor of Hospitalized Pneumonia Patients with Comorbidity: Car Score
Speaker: Paramita Khairan, Indonesia - 12:20–12:30
A New Criterion in Predicting 30-Day Mortality in Hospitalized Adult Patients with Infectious Diseases: A Retrospective Single Center Study
Speaker: Masafumi Shimoda, Japan - 12:30–12:40
Presence of Pneumonia in Patient with HIV in Developed Countries: A Systemic Review and Meta-Analysis
Speaker: Mohammed Khan, Malaysia
- 11:30–11:40
- 13:00–14:15
Lunch & Exhibition Viewing
Room: Exhibition Hall Sponsored Lunchtime Session 1: Rethinking severe asthma
Sponsored by AstraZeneca
Room: Theatrette 1, Exhibition Hall- 13:00–13:05
Welcome and introduction
Speaker: Phil Bardin, AU - 13:05–13:15
Severe asthma - bringing it back into the spotlight
Speaker: Phil Bardin, AU - 13:15–13:35
Severe uncontrolled asthma - why it is not just asthma?
Speaker: You Sook Cho, Republic of Korea - 13:35–14:00
Novel mechanisms of eosinophilia in severe asthma
Speaker: Parameswaran Nair, Canada - 14:00–14:15
Panel discussion and Q&Amp;A
Speaker: All speakers
- 13:00–13:05
Sponsored Lunchtime Session 2: Are all LAMA/LABA bronchodilators the same? Review of new evidence Sponsored by GSK
Room: Theatrette 2, Exhibition Hall- 13:00–13:10
Introduction
Speaker: Greg King, AU - 13:10–13:30
Overview of COPD management with a focus on the breathless patient
Speaker: Norbert Berend, AU - 13:30–13:50
Maximal bronchodilation with dual bronchodilators - the latest evidence
Speaker: Chris Compton, UK - 13:50–14:15
Q&Amp;A
Speaker: All speakers
- 13:00–13:10
- 14:15–15:45
COPD 1: COPD and the elderly
Room: Darling Harbour Theatre- 14:15–14:45
COPD and ageing; one way-traffic?
Speaker: Peter Barnes, UK - 14:45–15:15
COPD, CV disease morbidity and mortality
Speaker: Yoko Shibata, Japan - 15:15–15:45
Extra-pulmonary effects of severe COPD
Speaker: Darcy Marciniuk, Canada
- 14:15–14:45
Environmental and Occupational Health / Epidemiology: Fibre to fibrosis; dust to dust
Room: C3.3- 14:15–14:45
Clinical features of lung disease caused by organic and inorganic dusts
Speaker: Woo-Jin Kim, Republic of Korea - 14:45–15:15
Black is the new black - the re-emergent problem of black lung
Speaker: Deborah Yates, AU - 15:15–15:45
Genetic backgrounds and possible biomarkers for lung disease caused by low-dose exposure of fibrous dusts
Speaker: Andrew Churg, Canada
- 14:15–14:45
Paediatric 1: Pneumonia in childhood
Room: C3.4 & C3.5- 14:15–14:45
A modern tale of Orthrus: The prevention and treatment of pneumonia in children
Speaker: Keith Grimwood, AU - 14:45–15:15
Medical intervention for severe/complicated pneumonia
Speaker: Adam Jaffe, AU - 15:15–15:45
Surgical intervention for severe/complicated pneumonia
Speaker: Alan Sihoe, Hong Kong
- 14:15–14:45
Oral Presentations: Bronchoscopy and Interventional Techniques
Room: E3.9- 14:15–14:25
Diagnosis of Peripheral Lung Nodule Using Endobronchial Ultrasound with a Guide Sheath and CT Workstation: Preliminary Study
Speaker: Soohyun Bae, Republic of Korea - 14:25–14:35
The Utility of New 25 Gauge Endobronchial Ultrasound-Guided Transbronchial Needle in Lymph Node Staging
Speaker: Yuji Matsumoto, Japan - 14:35–14:45
Utility of Probe-Based Confocal Laser Endomicroscopy for Rapid Evaluation in Transbronchial Biopsy Specimens
Speaker: Masao Takemura, Japan - 14:45–14:55
A Review of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Use at Multiple Centres as Diagnostic Guide for Sarcoidosis
Speaker: Shu Han Emily Liu, AU - 14:55–15:05
Cryotherapy: New Concept in Paediatric Airway Disorders
Speaker: Mohammad Ashkan Moslehi, Iran - 15:05–15:15
The Utility of Virtual Fluoroscopy During Transbronchial Biopsy for not Visible Ground-Glass Nodules on X-Ray Fluoroscopy
Speaker: Toshiyuki Nakai, Japan - 15:15–15:25
Patients' Experiences During Flexible Bronchoscopy With Placebo and/or Various Pharmaceutical Agents: A Systematic Review
Speaker: Catherine Saxon, AU - 15:25–15:35
One-Year Outcomes of Bronchial Thermoplasty for Severe Uncontrolled Asthma in Japan
Speaker: Motoyasu Iikura, Japan
- 14:15–14:25
Oral Presentations: Respiratory Structure and Function
Room: E3.10- 14:15–14:40
Thunderstorm asthma - what has particle size got to do with it?
Speaker: Bruce Thompson, AU - 14:40–14:50
Agreement of Commonly used Prediction Equations for Spirometry Interpretation in Thai People
Speaker: Warawut Chaiwong, Thailand - 14:50–15:00
Non-Specific Ventilatory Limitation: Patient Characteristics, Associated Diagnoses and Radiological Changes
Speaker: Geak Poh Tan, Singapore - 15:00–15:10
Measurement of Airway Dimensions by 3-D CT in Inflammatory Bowel Disease Patients
Speaker: Suguru Majima, Japan - 15:10–15:20
High Speed, High Resolution In Vivo Dynamic Lung Imaging Using a Laboratory X-Ray Source to Measure Regional Lung Function and Pulmonary Vasculature
Speaker: Melissa Preissner, AU - 15:20–15:30
Acute Cigarette Smoke Exposure Impairs Airway Contraction but not Relaxation in Mouse Precision Cut Lung Slices
Speaker: Maggie Lam, AU
- 14:15–14:40
Poster Session
Room: Exhibition Hall- 15:45–16:15
Afternoon Tea & Exhibition Viewing
Room: Exhibition Hall - 16:15–17:45
Bronchoscopy and Interventional Techniques 1: Pleural disease state of the art
Room: Darling Harbour Theatre- 16:15–16:45
Pneumothorax
Speaker: Pyng Lee, Singapore - 16:45–17:15
Pleural infection
Speaker: Gary Lee, AU - 17:15–17:45
Malignant pleural effusion
Speaker: Anantham Devanand, Singapore
- 16:15–16:45
Cellular and Molecular Biology: Intrinsic and acquired cellular abnormalities in lung diseases
Room: C3.3- 16:15–16:45
Macrophage dysfunction in respiratory disease
Speaker: Louise Donnelly, UK - 16:45–17:15
Autophagy in airways disease
Speaker: Maria Sukkar, AU - 17:15–17:45
A novel endosomal NOX2 oxidase inhibitor protects against influenza A virus-induced disease
Speaker: Stavros Selemidis, AU
- 16:15–16:45
Paediatric 2: Childhood asthma - treatment and cohorts
Room: C3.4 & C3.5- 16:15–16:45
Greatest advances - worst mistakes
Speaker: Andrew Bush, UK - 16:45–17:15
Early life origins - what we've learnt from cohorts
Speaker: Peter Le Souef, AU - 17:15–17:45
Adolescent asthma - challenges and opportunities
Speaker: Susan Sawyer, AU
- 16:15–16:45
Oral Presentations: COPD 2
Room: E3.10- 16:15–16:25
Development of a New Short-Term Lung Emphysema Mouse Model
Speaker: Yu Mikami, Japan - 16:25–16:35
The Effects and Mechanism of Alendronate for COPD Animal Model
Speaker: Jin-Fu Xu, China - 16:35–16:45
Aging Related DNA Methylation in Peripheral Blood of Smokers and Patients with COPD
Speaker: Ling Qin, AU - 16:45–16:55
Abnormal M1/M2 Macrophage Phenotype Switching Occurs Differentially in the Small Airway Wall and Lumen in Smokers and Chronic Obstructive Pulmonary Disease (COPD)
Speaker: Mathew Eapen, AU - 16:55–17:05
Increased Upregulation of Lysosomal-Associated Membrane Protein 1 (LAMP-1) in the Airway Wall of COPD is Associated with Decreased Physiological Outcomes and Potential Role in Autophagy
Speaker: Mathew Eapen, AU - 17:05–17:15
Ciliary Dysfunction and Respiratory Epithelial Ultrastructural Abnormalities are Features of COPD Irrespective of Exacerbator Phenotype
Speaker: Biju Thomas, Singapore - 17:15–17:25
Sparc Expression in Airway Smooth Muscle Cells is Regulated by the Unfolded Protein Response and may be Diminished in Chronic Obstructive Pulmonary Disease
Speaker: Sharon Wong, AU
- 16:15–16:25
Oral Presentations: Respiratory Infections (Non-TB) 2
Room: E3.8- 16:15–16:25
A Single Centre, Prospective, Longitudinal Study of the Human Respiratory Virome after Lung Transplantation
Speaker: Alicia Mitchell, AU - 16:25–16:35
The First Case of Community-Acquired Invasive Pneumonia Due to K2 Serotype Hypervirulent Klebsiella Pneumoniae in an Adult Patient
Speaker: Jun Hirai, Japan - 16:35–16:45
Clinical Characteristics of Corynebacterium Pneumonia Patients: A Retrospective, Single Center Investigation
Speaker: Masahiro Nemoto, Japan - 16:45–16:55
Nodular Bronchiectasis with Positive Results for Serum Antibody to Mycobacterium Avium Complex, without an Early Definite Diagnosis of Pulmonary Mycobacterium-Avium-Complex Disease
Speaker: Shin Sasaki, Japan - 16:55–17:05
Prognostic Value of a B-Type Natriuretic Peptide in Patients with Pneumonia: A Prospective Cohort Study
Speaker: Kento Takeshima, Japan - 17:05–17:15
Prognosis Factors of Pneumocystis Jirovecii Pneumonia in Non-HIV Infected Patients
Speaker: Chia-Jung Liu, Taiwan
- 16:15–16:25
Oral Presentations: Respiratory Neurobiology and Sleep
Room: E3.9- 16:25–16:35
Longitudinal Assessment of Sleep Abnormalities in Patients with Severe Cystic Fibrosis
Speaker: Odette Erskine, AU - 16:35–16:45
Evidence of Association Between GABBR2 Gene Polymorphism and Obstructive Sleep Apnea Syndrome in Asthma Patients
Speaker: Denis Naumov, Russia - 16:45–16:55
Prodromal Obesity Hypoventilation Syndrome - Early Detection of Hypoventilation in the Very Obese Population
Speaker: Sheila Sivam, AU - 16:55–17:05
Effects of High Flow Oxygen Therapy on Oxygen Desaturation Index in Patients with Acute Ischemic Stroke
Speaker: Nattapong Wiboonsirichai, Thailand - 17:05–17:15
Regional Neural Control of Genioglossus in Wake and Sleep
Speaker: Yizhong Zheng, AU - 17:15–17:25
Assessment of Soft Palate Muscle Fatigue and its Effect on Velopharyngeal Upper Airway Dynamics
Speaker: Wenyang Li, China - 17:25–17:35
Acceptance of Upper Airway Muscle Training for Treatment by Obstructive Sleep Apnea: Results of a Prospective Survey
Speaker: Wenyang Li, China
- 16:25–16:35
Oral Presentations: Tuberculosis 2
Room: E3.4- 16:15–16:25
Performance of Different Sets of Single-Nucleotide Polymorphisms (SNP) for Typing Mycobacterium Tuberculosis(MTB) Strains Lineage and Modern/Ancient Beijing Sublineage
Speaker: Denise P. C. Chan, Hong Kong - 16:25–16:35
This presentation has been moved to Tuberculosis 3 oral session on Sunday - (Study of Diagnostic Utility of Xpert MTB/RIF Test on Pleural Fluid in the Evaluation of Patients Presenting with Pleural Tuberculosis in Nepal)
Speaker: Deebya Raj Mishra, Nepal - 16:35–16:45
Diagnostic Accuracy of Two Nucleic Acid Amplification Tests for Rapid Diagnosis of Tuberculous Pleural Effusion
Speaker: Muhammad Irfan, Pakistan - 16:45–16:55
The Correlation Between Xpert MTB/RIF Level Category with Sputum Culture Conversion Time in Drug Resistant Tuberculosis (TB) Patients
Speaker: Harsini Hartono Sudarmo, Indonesia - 16:55–17:05
AFB Smear M.TB on Adult Pulmonary TB Patients with Type 2 DM and Without: A Cross Sectional Study in General Hospital North Jakarta Indonesia
Speaker: Muhammad Fachri, Indonesia - 17:05–17:15
T-Spot TB Test and Clinical Risk Scores for Latent Tuberculosis Infection Diagnosis Among Thai Healthcare Workers
Speaker: Waralee Aksornchindarat, Thailand - 17:15–17:25
Role of CBNAAT in the Early Detection of Rifampicin Resistance in Retreatment Cases of Pulmonary and Extrapulmonary Tuberculosis
Speaker: Zuber Ahmad, India
- 16:15–16:25
